Marius pharmaceuticals and hims & hers™ collaborate to expand access to kyzatrex® (testosterone undecanoate) ciii capsules, the first fda-approved oral testosterone therapy offered on the hims & hers platform

Raleigh, n.c., sept. 10, 2025 (globe newswire) -- marius pharmaceuticals, inc. today announced a collaboration with hims & hers™, one of the largest digital health platforms for men, to make kyzatrex® , an fda-approved oral testosterone replacement therapy for adult men with low or no testosterone levels due to certain medical conditions, available to patients through the hims & hers platform in the coming months. this marks the first time hims & hers will offer an fda-approved oral testosterone therapy, underscoring kyzatrex's position as a leader in the testosterone therapy space.
HIMS Ratings Summary
HIMS Quant Ranking